BIO08027 2019 Biopharmaceutical Validation
Full Title
Biopharmaceutical Validation
Transcript Title
Biopharmaceutical Validation
Code
BIO08027
Attendance
N/A %
Subject Area
BIO - Bio Tech/Eng/Chem
Department
LIFE - Life Sciences
Level
08 - Level 8
Credit
05 - 05 Credits
Duration
Semester
Fee
€
Start Term
2019 - Full Academic Year 2019-20
End Term
9999 - The End of Time
Author(s)
Kieran Tobin, Stephen Daly
Programme Membership
SG_SMEDI_H08 201900 Bachelor of Science (Honours) in Medical Biotechnology
SG_SMEDI_K08 201900 Bachelor of Science (Honours) in Medical Biotechnology
SG_SBIOS_H08 202300 Bachelor of Science (Honours) in Biomedical Science
SG_SBIOS_K08 202300 Bachelor of Science (Honours) in Biomedical Science
Description
This course aims to provide the student with a broad understanding of the various aspects of process and support systems validation for the manufacturing of modern biopharmaceuticals. It will highlight and evaluate the various risks inherent in bioprocessing and how the application of effective validation methodologies assists in the control and management of such risks.
Learning Outcomes
On completion of this module the learner will/should be able to;
1.
Describe the key elements in a systematic approach to validation with particular emphasis on their application to bioprocessing.
2.
Understand and apply the key elements of equipment qualification and analytical test method validation.
3.
Categorise the principal risks associated with the manufacture of modern biopharmaceuticals and tools to evaluate them
4.
Evaluate the main steps involved in the process validation of upstream (cell culture processing) and downstream (protein purification) processes.
5.
Explain the validation approaches for cleaning, sterilisation and viral control technologies in the manufacture of biopharmaceuticals.
6.
Communicate and explain scientific data relating to biopharmaceutical validation.
Teaching and Learning Strategies
This module is taught face to face in the lecture room. It will combine a number of strategies including visualisation (e.g. audio clips), group work and some enquiry based learning. Lecture content will be the primary method towards achieving this. However, some workshops will be set up in the class giving students scenarios to work through and apply what they have learned.
Module Assessment Strategies
Assessment of the Biopharmaceutical Validation module will include a combination of both continuous assessment and a terminal exam. The continuous assessment will be broken into multiple choice question exams and projects/workshop write-ups. A key focus of this module is to develop the student's team skills. To achieve this, students will be assigned a validation project and be expected to participate constructively within a complex team environment. The team project will require the student's to work together to solve complex technical problems, plan for effective project implementation and manage the organisation of tasks, people and resources.
Repeat Assessments
Students will have opportunities to re-submit work or repeat the terminal exam as agreed with their lecturer
Indicative Syllabus
Overview of Validation Methodologies with specific application to Biopharmaceutical Manufacture.
Understand the concept of the validation life cycle
Risk Identification, Risk Assessment and Risk Management for Biopharmaceutical Manufacture e.g. FMEA.
Process Validation for Upstream Processing - Cell Culture Processing.
Process Validation for Downstream Processing - Protein Purification.
Validation Methodology for Viral Control of Biopharmaceuticals.
Equipment Qualification (CQV) and V model for validation
Analytical Method Validation.
Cleaning and Sterilisation Validation.
Understand the relationship between Validation, Technology Transfer and Product Life Cycle.
Coursework & Assessment Breakdown
Coursework & Continuous Assessment
40 %
End of Semester / Year Formal Exam
60 %
Coursework Assessment
| Title | Type | Form | Percent | Week | Learning Outcomes Assessed | |
|---|---|---|---|---|---|---|
| 1 | MCQ 1 | Coursework Assessment | Multiple Choice/Short Answer Test | 10 % | Week 6 | 1,2 |
| 2 | MCQ 2 | Coursework Assessment | Multiple Choice/Short Answer Test | 10 % | Week 12 | 3,4,5 |
| 3 | Project | Coursework Assessment | Project | 20 % | Week 10 | 2,3,4,5,6 |
End of Semester / Year Assessment
| Title | Type | Form | Percent | Week | Learning Outcomes Assessed | |
|---|---|---|---|---|---|---|
| 1 | Final Exam | Final Exam | Closed Book Exam | 60 % | End of Term | 1,2,3,4,5,6 |
Full Time Mode Workload
| Type | Location | Description | Hours | Frequency | Avg Workload |
|---|---|---|---|---|---|
| Lecture | Tiered Classroom | Lecture | 1 | Weekly | 1.00 |
| Problem Based Learning | Flat Classroom | Problem Based Learning | 1 | Weekly | 1.00 |
| Independent Learning | UNKNOWN | Self Study | 5 | Weekly | 5.00 |
Total Full Time Average Weekly Learner Contact Time 1.00 Hours
Required & Recommended Book List
Required Reading
2017-11 Biopharmaceutical Processing
ISBN 0081006233 ISBN-13 9780081006238
2017-11 Biopharmaceutical Processing
ISBN 0081006233 ISBN-13 9780081006238
Biopharmaceutical Processing: Development, Design, and Implementation of Manufacturing Processes covers bioprocessing from cell line development to bulk drug substances. The methods and strategies described are essential learning for every scientist, engineer or manager in the biopharmaceutical and vaccines industry. The integrity of the bioprocess ultimately determines the quality of the product in the biotherapeutics arena, and this book covers every stage including all technologies related to downstream purification and upstream processing fields. Economic considerations are included throughout, with recommendations for lowering costs and improving efficiencies. Designed for quick reference and easy accessibility of facts, calculations and guidelines, this book is an essential tool for industrial scientists and managers in the biopharmaceutical industry. Offers a comprehensive, go-to reference for daily work decisions Covers both upstream and downstream processes Includes case studies that emphasize financial outcomes Presents summaries, decision grids, graphs and overviews for quick reference
Required Reading
2007-09-25 Validation of Pharmaceutical Processes, Third Edition CRC Press
ISBN 0849370558 ISBN-13 9780849370557
2007-09-25 Validation of Pharmaceutical Processes, Third Edition CRC Press
ISBN 0849370558 ISBN-13 9780849370557
Completely revised and updated to reflect the significant advances in pharmaceutical production and regulatory expectations, this third edition of Validation of Pharmaceutical Processes examines and blueprints every step of the validation process needed to remain compliant and competitive. The many chapters added to the prior compilation examine validation and six sigma system design; the preparation of aseptic and non-aseptic pharmaceutical products; active pharmaceutical ingredient and biotechnology processes, computerized systems; qualification and cleaning of equipment; analytical methods, calibration and certification. As the industry's leading source for validation of sterile pharmaceutical processes for more than 10 years, this greatly expanded is a comprehensive analysis of all of the fundamental elements of this arena with practical solutions for every pharmaceutical and bio-pharmaceutical production process. Presenting theoretical knowledge and applied practical considerations, this title provides an in-depth discussion of recent advances in sterilization identifies obstacles that may be encountered at any stage of the validation program, and suggests the newest and most advanced solutions explores distinctive and specific process steps, and identifies critical process control points to reach acceptable results blends the use of theoretical knowledge with recent technological advancements to achieve applied practical solutions
Required Reading
1998-10-31 Biotechnology CRC Press
ISBN 1574910892 ISBN-13 9781574910896
1998-10-31 Biotechnology CRC Press
ISBN 1574910892 ISBN-13 9781574910896
Biotechnology: Quality Assurance and Validation provides a practical, detailed discussion of what issues Quality Assurance and Quality Control need to identify for effective control in the preparation of biotechnology products. The book presents a series of topics that define some of the unique challenges facing biotechnology companies in producing biopharmaceutical products. The topics selected address quality and validation issues, starting with the cryopreservation of cell lines through the filling and finishing of the product. It includes a validation guide, a clear presentation of how to use filtration effectively, a synoptic view of cleaning procedures, and much more.
Required Reading
2007-08-13 Pharmaceutical Biotechnology John Wiley & Sons
ISBN 9780470012444 ISBN-13 0470012447
2007-08-13 Pharmaceutical Biotechnology John Wiley & Sons
ISBN 9780470012444 ISBN-13 0470012447
Offers a comprehensive introduction to the principles and concepts of pharmaceutical biotechnology.
Required Reading
2002 Bioprocess Engineering Pearson College Division
ISBN 0130819085 ISBN-13 9780130819086
2002 Bioprocess Engineering Pearson College Division
ISBN 0130819085 ISBN-13 9780130819086
This concise yet comprehensive text introduces the essential concepts of bioprocessing - internal structure and functions of different types of microorganisms, major metabolic pathways, enzymes, microbial genetics, kinetics and stoichiometry of growth and product information - to traditional chemical engineers and those in related disciplines. It explores the engineering principles necessary for bioprocess synthesis and design, and illustrates the application of these principles to modern biotechnology for production of pharmaceuticals and biologics, solution of environmental problems, production of commodities, and medical applications.
Module Resources
Non ISBN Literary Resources
See Booklist
Journal Resources
'Process Validation of Protein Manufacturing'. PDA Journal of Pharmaceutical Science and Technology. Technical Report No. 42.
URL Resources
https://www.fda.gov
https://www.ema.europa.eu
www.ICH.org
https://ec.europa.eu/health/documents/eudralex/vol-4_en
Other Resources
None
Additional Information
None